The OCE PFDD program fosters collaboration between FDA centers and external stakeholders involved in patient outcomes research in cancer populations.
Similar Posts
Compounding Quality Center of Excellence | Instructor-Led Trainings
The Compounding Quality Center of Excellence’s free in-person training programs target outsourcing facility staff and offer continuing education credits. The training will open for state regulators and pharmacy compounders if space is available.VITAFER-L Gold 500ml may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use VITAFER-L Gold 500ml, a product promoted for energy and sexual enhancement on various websites, including www.amazon.com and www.walmart.com.Alembic Pharmaceuticals Limited – 02/06/2021
Alembic Pharmaceuticals Limited – 02/06/2021. Country: India. Record Type: 483M14 General Principles on Planning, Designing, Analyzing, and Reporting of Non-interventional Studies That Utilize Real-World Data for Safety Assessment of Medicines
M14 General Principles on Planning, Designing, Analyzing, and Reporting of Non-interventional Studies That Utilize Real-World Data for Safety Assessment of MedicinesUpdate: FDA Encourages the Public to Follow Established Choking Rescue Protocols – FDA Safety Communication
These choking rescue protocols include abdominal thrusts (also called the “Heimlich” maneuver) for children and adults but not anti-choking devices.CDER’s Framework for Regulatory Advanced Manufacturing Evaluation (FRAME) Initiative
CDER’s Framework for Regulatory Advanced Manufacturing Evaluation (FRAME) Initiative